MTARC1 and metabolic dysfunction-associated steatotic liver disease: Although the precise role and physiological function of MARC1 are unknown, it has been proposed that this lipid phenotype may hint at a possible physiological mechanism by which MARC1 could participate in NAFLD [12,30].